Oxira 8 Mg Lornoxicam - 20 Tablets
???? يُصرف بوصفة طبية فقط
Oxira 8 Mg Lornoxicam - 20 Tablets represent a highly effective pharmacological option belonging to the non-steroidal anti-inflammatory drug (NSAID) class. The mechanism of action of Oxira 8 Mg Tablets is fundamentally driven by the active ingredient Lornoxicam, which acts as a potent analgesic and anti-inflammatory agent through the robust inhibition of cyclooxygenase enzymes, thereby preventing the synthesis of pain-signaling prostaglandins and providing substantial relief for patients with chronic joint pain.
When are Oxira 8 Mg Tablets indicated for use?
- Short-term symptomatic treatment of acute, mild to moderate pain in adult patients.
- Effective symptomatic relief of deep pain and debilitating inflammation in osteoarthritis.
- Rigorous control of acute pain, extreme stiffness, and swelling associated with rheumatoid arthritis.
- Targeted palliation for generalized, severe inflammatory musculoskeletal pain.
Benefits and Features
- Profoundly and effectively curtails the synthesis of prostaglandins driving the inflammatory response.
- Significantly contributes to enhancing overall joint mobility and sharply reducing morning stiffness.
- Exhibits a potent analgesic profile that clinically rivals certain centrally acting analgesics in acute settings.
- The 8 mg formulation provides excellent clinical flexibility in titrating dosages according to pain severity.
How to Use
- The standard adult posology ranges strictly between 8 to 16 mg daily, meticulously divided into two or three doses.
- For patients suffering from arthritis, the highly recommended daily dose is 12 mg, appropriately divided.
- The absolute maximum permissible daily dose is 16 mg, which must never be exceeded to preclude severe systemic toxicity.
- Swallow the tablets completely whole with an ample volume of water, preferably post-prandially to minimize gastric distress.
Warnings and Precautions
- Strictly contraindicated in patients presenting with active peptic ulceration or a documented history of severe gastrointestinal bleeding.
- Absolute contraindication for patients with severe heart failure or in the perioperative setting of coronary artery bypass graft surgery.
- Must be administered with extreme caution in patients with diagnosed hypertension, renal impairment, or hepatic dysfunction.
- Strictly contraindicated during pregnancy (most notably the third trimester) and throughout the entire duration of lactation.
Frequently Asked Questions
- Can Oxira be routinely utilized as a standard analgesic for migraines or simple toothaches?
- Oxira is primarily indicated for acute inflammatory and severe articular pain. Although it is a formidable general analgesic, a physician must dictate its usage priority by meticulously weighing the potential severe gastrointestinal and cardiovascular risks against the efficacy of milder, alternative analgesics.
- What severe pharmacological interactions must be actively avoided while on this medication?
- It is imperative to absolutely avoid concomitant administration with anticoagulants (e.g., Warfarin) due to the sharply amplified risk of catastrophic bleeding. Co-administration with Aspirin and other NSAIDs is forbidden, and extreme caution is required when utilized alongside diuretics and anti-hypertensive agents.
- Does the administration of this medication precipitate an elevation in systemic blood pressure?
- Yes. Consistent with the pharmacological profile of the NSAID class, Lornoxicam can definitively induce fluid retention, directly elevate systemic blood pressure, and dangerously antagonize the efficacy of concurrent anti-hypertensive therapies, mandating rigorous blood pressure monitoring.
For optimal use, consult a pharmacist.
